Citadel Advisors’s ESSA Pharma EPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-144,449
Closed -$27.6K 13062
2025
Q3
$27.6K Buy
144,449
+90,410
+167% +$108K ﹤0.01% 12422
2025
Q2
$91.9K Sell
54,039
-28,084
-34% -$47.4K ﹤0.01% 11409
2025
Q1
$130K Sell
82,123
-76,918
-48% -$130K ﹤0.01% 11089
2024
Q4
$285K Buy
159,041
+130,562
+458% +$416K ﹤0.01% 9759
2024
Q3
$173K Buy
28,479
+3,354
+13% +$18.4K ﹤0.01% 10364
2024
Q2
$132K Sell
25,125
-11,393
-31% -$72.4K ﹤0.01% 10526
2024
Q1
$310K Sell
36,518
-227,089
-86% -$1.98M ﹤0.01% 9383
2023
Q4
$1.74M Buy
263,607
+258,132
+4,715% +$1.27M ﹤0.01% 5615
2023
Q3
$16.9K Sell
5,475
-5,408
-50% -$15.6K ﹤0.01% 12755
2023
Q2
$29.4K Buy
+10,883
New +$31.9K ﹤0.01% 12373
2023
Q1
Hold
0
14919
2022
Q4
Hold
0
15020
2022
Q3
Hold
0
12945
2022
Q2
Hold
0
13226
2022
Q1
Sell
-483,897
Closed -$4.25M 13879
2021
Q4
$6.87M Sell
483,897
-201,634
-29% -$2.25M 0.01% 3751
2021
Q3
$5.49M Sell
685,531
-35,170
-5% -$559K 0.01% 4132
2021
Q2
$20.6M Buy
720,701
+234,042
+48% +$6.8M 0.02% 2041
2021
Q1
$14.1M Buy
486,659
+85,047
+21% +$1.98M 0.01% 2461
2020
Q4
$4.79M Sell
401,612
-732
-0.2% -$5.15K 0.01% 3768
2020
Q3
$2.78M Buy
+402,344
New +$2.73M ﹤0.01% 4110
2018
Q2
Sell
-2,682
Closed -$10K 8959
2018
Q1
$10K Buy
2,682
+603
+29% +$2.51K ﹤0.01% 8181
2017
Q4
$9K Sell
2,079
-1,092
-34% -$5.68K ﹤0.01% 7895
2017
Q3
$18K Buy
3,171
+2,228
+236% +$15.5K ﹤0.01% 7377
2017
Q2
$10K Buy
+943
New +$30.8K ﹤0.01% 7372